KPL
- Company typePrivate
- Founded-
- HeadquartersMilford, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What KPL does
KPL (Kirkegaard & Perry Laboratories) operates as an immunoassay reagent product line within SeraCare, the clinical diagnostics brand of LGC Clinical Diagnostics, Inc., a Massachusetts-incorporated subsidiary of UK-based LGC Group. The KPL line supplies ready-to-use antibodies, conjugates, and immunoassay reagent kits to in vitro diagnostic (IVD) assay developers, clinical laboratories, and research institutions that need standardized biological materials to validate and accelerate diagnostic test development. KPL's commercial context is the broader SeraCare portfolio, which spans Seraseq next-generation sequencing (NGS) reference standards, ACCURUN molecular and serology quality controls, AccuVert seroconversion panels, AccuSet performance panels, AccuTrak qualification panels, AccuSpan linearity panels, AccuPlex recombinant virus reference materials, and Virusys viral disease antibodies and controls.
The underlying technology is fundamentally biological rather than digital: characterized patient-derived specimens (e.g., raw undiluted plasma, serially drawn seroconversion samples), recombinant virus constructs for unculturable or high-containment pathogens, formalin-fixed paraffin-embedded (FFPE) materials, and affinity-purified antibody/conjugate reagents, each accompanied by batch-level certificates of analysis and comparative test data sheets across leading IVD platforms. Manufacturing is anchored at three US sites — Milford, MA (headquarters), Gaithersburg, MD, and Cumberland Foreside, ME — supporting both catalog production and custom OEM/bulk processing work. Distribution is direct via the seracare.com e-commerce storefront (account-gated pricing) plus account-based OEM sales to leading diagnostic assay developers, with global shipping across North America, Western Europe, and East Asia. The business model is predominantly one-time catalog sales of reference materials and immunoassay reagents, supplemented by custom services (custom NGS libraries, EQA proficiency panels, prospective collections, bulk processed plasma and serum) priced as professional services engagements.
KPL firmographics
Firmographics- Name
- KPL
- Legal name
- LGC Clinical Diagnostics, Inc.
- Website
- https://kpl.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
KPL industry classification
Industry- Product category
- Diagnostic Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
- akta.pro secondary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where KPL is headquartered
LocationHeadquarters
- HQ city
- Milford
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
KPL business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Revenue model
- KPL Immunoassay Products: Sale of antibodies, conjugates, and immunoassay reagents/kits to IVD assay developers and clinical laboratories for research and diagnostic assay development purposes
- Reference Materials & Controls: Sale of NGS reference standards, seroconversion panels, performance panels, qualification panels, and linearity panels to clinical laboratories and IVD manufacturers
- Custom Services: Custom NGS solutions, molecular and serology controls and panels, EQA proficiency panels, antibodies and reagents, prospective collections, and bulk processed plasma and serum services for assay developers
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | KPL Antibodies & Conjugates |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
KPL product offering
Product offeringCore offering
KPL (Kirkegaard & Perry Laboratories) is a product line and sub-brand of SeraCare Life Sciences (LGC Clinical Diagnostics) that manufactures and sells ready-to-use antibodies, conjugates, and immunoassay reagent kits. These products are designed to accelerate research workflows and in vitro diagnostic (IVD) assay development for clinical laboratories, IVD manufacturers, and assay developers.
Product overview
KPL (Kirkegaardgaard & Perry Laboratories) is a sub-brand of SeraCare Life Sciences offering two complementary product lines for immunoassay development: KPL Antibodies & Conjugates (providing antibodies and conjugate reagents) and KPL Immunoassay Reagents & Kits (providing assay reagents and kit solutions). These products are positioned within SeraCare's broader portfolio of quality control tools for clinical laboratories, including NGS reference materials, serology controls, and infectious disease assay tools. The KPL products serve as readily available reagents to accelerate research and IVD assay development, fitting into SeraCare's ecosystem alongside their Seraseq reference materials, ACCURUN controls, and AccuSpan/AccuVert/AccuTrak panel products.
Differentiator
Problem solved
Functional benefit
Brands
- KPL: KPL (Kirkegaard & Perry Laboratories) provides antibodies, conjugates, immunoassay reagents and kits for research and IVD assay development.
- Seraseq
- ACCURUN
- AccuVert
- AccuSet
- AccuTrak
- AccuSpan
- Virusys
Products and services
- KPL Antibodies & Conjugates A comprehensive line of ready-to-use antibodies and conjugates for immunoassay development, providing readily available reagents to accelerate research and IVD (in vitro diagnostic) assay development. Targeted at IVD assay developers, clinical laboratories, and research institutions developing immunoassays and diagnostic tests.
- KPL Immunoassay Reagents & Kits A range of complete immunoassay reagent kits designed to support research and IVD assay development workflows with readily available materials, intended to accelerate development timelines for diagnostic assay developers.
Companies that use KPL
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
KPL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
KPL partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
KPL competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Roche Diagnostics is a global IVD leader across molecular, immunoassay, and clinical chemistry. It represents both an overlapping reference material/QC capability and a key end-customer segment that purchases OEM reference standards for its own assay development.
- Thermo Fisher Scientific: Thermo Fisher offers a broad portfolio of diagnostic reference materials, immunoassay reagents, and clinical QC tools through its Specialty Diagnostics and Life Sciences Solutions segments. It overlaps with SeraCare/KPL across antibodies, controls, and NGS reference standards but at much larger scale and broader scope.
- QuidelOrtho: QuidelOrtho is a major IVD manufacturer with extensive immunoassay and infectious disease testing capabilities. It is a partial peer through its proprietary assay development but also a customer of reference materials like those SeraCare/KPL provides.
Direct peers
- ZeptoMetrix: ZeptoMetrix (part of Antylia Scientific) specializes in infectious disease reference materials, seroconversion panels, and viral antigens — directly overlapping with SeraCare's AccuVert, AccuSet, and Virusys product lines for IVD assay developers.
- Bio-Rad Laboratories: Bio-Rad is one of the largest manufacturers of IVD quality controls, reference materials, and specialty diagnostics reagents. It directly competes with SeraCare/KPL across molecular QC, serology controls, and immunoassay reagents, serving the same clinical lab and IVD developer customers.
- Streck: Streck develops clinical lab quality controls, stabilization products, and reference materials for hematology, molecular, and infectious disease testing. It competes head-to-head with SeraCare's ACCURUN and panel products in clinical laboratory QC workflows.
- Surmodics: Surmodics' Diagnostics division provides IVD reagents, antigens, antibodies, and OEM assay components to diagnostic manufacturers — a directly comparable offering to KPL's antibodies, conjugates, and immunoassay reagent kits.
Others
- SeraCare Life Sciences (parent brand): SeraCare is the umbrella commercial brand under which KPL operates; included as a peer to clarify the parent-brand relationship rather than as a true external competitor (it is the same legal entity, LGC Clinical Diagnostics, Inc.).
Emerging players
- ATCC: ATCC provides biological reference materials, cell lines, and microbial standards used in assay development and QC. It overlaps with SeraCare's disease state specimens and recombinant virus materials for select IVD and research applications.
- Maine Biotechnology Services: Maine Biotechnology Services specializes in custom antibody development and immunoassay reagents for IVD and research applications, overlapping with KPL's antibody and conjugate offerings for smaller-volume or custom OEM needs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
KPL social profiles
Digital presenceKPL financial estimates
Financial estimateRevenue estimate
Valuation estimate
KPL leadership team
Management profileNumber of profiles
KPL subsidiaries and ownership
Company hierarchySubsidiaries1 record
KPL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KPL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KPL
What does KPL do?
KPL (Kirkegaard & Perry Laboratories) is a product line and sub-brand of SeraCare Life Sciences (LGC Clinical Diagnostics) that manufactures and sells ready-to-use antibodies, conjugates, and immunoassay reagent kits. These products are designed to accelerate research workflows and in vitro diagnostic (IVD) assay development for clinical laboratories, IVD manufacturers, and assay developers.
Is KPL a public or private company?
KPL is a private company. It is classified as corporate owned and is currently operating.
When was KPL founded?
KPL was founded in -1. It employs 11 to 50 people.
Where is KPL based?
KPL is headquartered in Milford, United States, in the North America region.
How does KPL make money?
Three revenue lines are on record. KPL Immunoassay Products are the primary driver. The others are reference Materials & Controls and custom Services.
Who are KPL's main competitors?
Broad incumbents on record are Roche Diagnostics, Thermo Fisher Scientific and QuidelOrtho. Direct peers are ZeptoMetrix, Bio-Rad Laboratories, Streck and Surmodics. SeraCare Life Sciences (parent brand) is listed as an others. Emerging players are ATCC and Maine Biotechnology Services.
Does KPL have an API?
No public API is recorded for KPL.
What industry is KPL in?
KPL's product category is Diagnostic Reagents. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.